Quick Peek

1. Eli Lilly's Q4 Miss – Why analysts are optimistic despite a tough quarter.

2. Orange & Vodacom Expand – Solar-powered innovation for connectivity in the DRC.

3. Meta's Performance Pivot – Cutting underperformers to tighten focus.

4. FTC Exposes PBMs – $7.3 billion in inflated drug prices: what it means for healthcare.

5. Reinet’s BAT Exit – Rupert dynasty bids farewell to a legacy stake.

6. Boeing's Low Delivery Forecast – Pandemic-level numbers for 2024.

7. FDA Labeling Controversy – A judge halts graphic warnings on cigarette packs.

Eli Lilly’s Q4 Miss: Why Analysts Say ‘Buy the Dip’

Shares of Eli Lilly took a hit after missing Q4 expectations, but analysts at Bank of America remain bullish, urging investors to capitalize on the temporary setback. The dip is seen as a buying opportunity, with confidence in the company’s long-term growth trajectory driven by its innovation pipeline.Read the full article here.

On the topic of innovation…

Orange and Vodacom: Solar-Powered Mobile Expansion in the DRC

A groundbreaking partnership between Orange and Vodacom is bringing solar-powered mobile coverage to underserved areas in the Democratic Republic of Congo. This initiative aims to bridge the connectivity gap while promoting sustainable energy solutions.Read the full article here.

Shifting to corporate strategies…

Meta Plans to Cut 5% of Low Performers

In a bid to enhance efficiency, Meta Platforms will cut ties with 5% of its underperforming employees. This move is part of the company’s broader strategy to remain competitive and improve profitability.Read the full article here.

Diving into healthcare costs…

FTC Report: Pharmacy Benefit Managers Inflate Drug Prices

The FTC revealed that major pharmacy benefit managers inflated drug prices by a whopping $7.3 billion, raising concerns that PBMs operate in ways that can lead to higher costs for patients and insurers.Read the full article here.

From pharmaceuticals to tobacco…

Reinet Investments Sells BAT Stake for $1.2 Billion

In a historic move, Reinet Investments has exited its stake in British American Tobacco, marking the end of an era for the Rupert dynasty. The sale underscores a strategic pivot for Reinet as it explores diversified investments.Read the full article here.

Speaking of the changing skies…

Boeing Forecasts Low Deliveries for 2024

Boeing projects its 2024 jet deliveries will drop to their lowest levels since the pandemic, citing ongoing production challenges. The company faces mounting pressure to meet rising demand amid supply chain disruptions.Read the full article here.

Ending with regulatory news…

Judge Blocks FDA’s Graphic Cigarette Warning Rule

A U.S. judge has halted the FDA's mandate requiring graphic warning labels on cigarette packages, raising debates over public health versus freedom of speech.Read the full article here.

Fill the French Press